Rtw Investments, LP Arvinas, Inc. Transaction History

Rtw Investments, LP

$6.1 Billion
Q1 2025

A detailed history of Rtw Investments, LP transactions in Arvinas, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 3,334,308 shares of ARVN stock, worth $25.3 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

3,334,308

Previous 3,334,308 -0.0%

Holding current value

$25.3 Million

Previous $63.9 Million 63.38%

% of portfolio

0.38%

Previous 1.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$17.83 - $28.04 $9.84 Million - $15.5 Million	551,979 Added 19.84%	3,334,308 $63.9 Million
Q3 2024 Nov 14, 2024	SELL	$23.66 - $32.73 $4.39 Million - $6.07 Million	-185,568 Reduced 6.25%	2,782,329 $68.5 Million
Q2 2024 Aug 14, 2024	SELL	$24.46 - $40.4 $8.07 Million - $13.3 Million	-330,000 Reduced 10.01%	2,967,897 $79 Million
Q1 2024 May 15, 2024	SELL	$36.38 - $52.31 $33.3 Million - $47.9 Million	-915,586 Reduced 21.73%	3,297,897 $136 Million
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $59.8 Million - $178 Million	4,213,483 New	4,213,483 $173 Million
Q2 2021 Aug 13, 2021	SELL	$60.45 - $84.26 $98.1 Million - $137 Million	-1,622,799 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$58.19 - $91.37 $9.79 Million - $15.4 Million	-168,197 Reduced 9.39%	1,622,799 $107 Million
Q4 2020 Feb 16, 2021	BUY	$20.19 - $84.93 $36.2 Million - $152 Million	1,790,996 New	1,790,996 $152 Million
Q3 2020 Nov 16, 2020	SELL	$22.99 - $36.34 $4 Million - $6.33 Million	-174,118 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$29.88 - $56.74 $5.1 Million - $9.69 Million	-170,819 Reduced 49.52%	174,118 $5.84 Million
Q1 2020 May 15, 2020	SELL	$33.0 - $54.5 $10.7 Million - $17.7 Million	-325,358 Reduced 48.54%	344,937 $13.9 Million
Q4 2019 Feb 14, 2020	SELL	$15.39 - $44.38 $2.14 Million - $6.18 Million	-139,328 Reduced 17.21%	670,295 $27.5 Million
Q3 2019 Nov 14, 2019	BUY	$21.55 - $27.61 $37,777 - $48,400	1,753 Added 0.22%	809,623 $17.4 Million
Q2 2019 Aug 14, 2019	SELL	$15.96 - $23.8 $1.73 Million - $2.59 Million	-108,644 Reduced 11.85%	807,870 $17.8 Million
Q1 2019 May 15, 2019	BUY	$13.55 - $23.79 $12.4 Million - $21.8 Million	916,514 New	916,514 $13.5 Million

Others Institutions Holding ARVN

# of Institutions

249

Shares Held

62.5M

Call Options Held

2.65M

Put Options Held

1.1M

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $403M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Account

Rtw Investments, LP Arvinas, Inc. Transaction History